Usefulness of ceramic prosthesis in total hip replacement
Augustovski F, Pichon Riviere A, Alcaraz A, Bardach A, Ferrante D, Garcia Marti S, Glujovsky D, Lopez A, Regueiro A
Record ID 32005001236
Spanish
Authors' objectives:
This report is intended to assess the use of ceramic prostheses for total hip replacement compared with other existing materials (such as metal and polyethylene).
Authors' results and conclusions:
Fifty seven articles were found, of which 6 were chosen (Randomized clinical trial, three case series and one non-randomized controlled trial) for further evaluation. At the same time, two sanitary technological evaluations and three reports on coverage policies were included. The clinical trials that compared ceramic against conventional prostheses found no significant differences in the rates of prosthesis revision among the different types. In the case series of patients with the ceramic prosthesis analyzed, revision rates of prostheses at 10 years lower than 10% were found, which is considered within acceptable limits and comparable to those reported for conventional prostheses. Some health organizations at present cover both metallic and ceramic prostheses.
Authors' recommendations:
Although intermediate results with this new material are promising, no significant differences were observed regarding revision rates for the present follow-up periods (10 and 15 years). Because the advantages of this material could be observed at longer terms, its potential benefits would be for younger patients (under 50 years of age) who need to use a prosthesis for a longer period of time in their lives.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.iecs.org.ar/
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Arthroplasty, Replacement, Hip
- Biocompatible Materials
- Ceramics
- Hip Prosthesis
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.